Abstract:Background: Computational models in medical research which use molecular features to predict patient sensitivities or outcomes are traditionally limited to producing a scalar output for a given disease phenotype, e.g. progression-free survival or drug response. Even for relatively intelligible models, it is generally difficult to place confidence limits on the prediction or develop an intuition for how a prediction varies with respect to "what-if" changes in those features or how sensitive a prediction is to changes in input variables. Moreover, while essential for understanding and modeling tumor behavior, molecular features from patient tumors in real-world settings are typically limited to profiles of hundreds of genes, while the biologically relevant inputs to the patient's condition can be much larger. Approach: To generate data required to enhance the interpretation of predictive models and extend the utility of real-world patient oncology datasets, a distribution of conditions consistent with the observed features and their incidence across cancer patient cohorts is required. We hypothesized we could synthesize patient samples drawn from the joint probability distribution of a broader universe of features when a subset of them is held fixed at the observed values. We model this joint distribution by learning a Bayesian network over a broad feature set for which some training data is available and generate feature profiles by applying Gibbs sampling to the learned network. Results: We assessed the potential clinical utility of using these generated feature profiles in predicting drug response and enhancing biological interpretation of different model outputs. We found generative somatic mutations were useful for predicting cancer patient outcomes, including drug response predictions in breast cancer tumors from AACR Project GENIE. Synthesized patient feature profiles enhanced biological interpretability of nominal panel data (100-200 genes), providing a means to assign probabilities to outcomes and uncovering previously described mechanisms of drug response in real-world patient data. Conclusion: We introduce an approach that leverages Bayesian networks to synthesize richly annotated patient feature profiles from limited molecular data routinely collected in real-world settings. This approach addresses challenges associated with limited molecular data, biological interpretability and evaluation of predictive models and enhances the utility of real-world datasets for cancer research. Citation Format: Dillon H. Tracy, Jeff Sherman, Maayan Baron. Generative Bayesian networks for augmentation of molecular data from commercial genetics panels [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 7373.

Bayesian Illumination: Inference and Quality-Diversity Accelerate Generative Molecular Models

Enhancing molecular design efficiency: Uniting language models and generative networks with genetic algorithms

Advances in Deep Learning-Based 3D Molecular Generative Models

Generative models for molecular discovery: Recent advances and challenges

Probabilistic Generative Deep Learning for Molecular Design

Particle Guidance: non-I.I.D. Diverse Sampling with Diffusion Models

On The Difficulty of Validating Molecular Generative Models Realistically: A Case Study on Public and Proprietary Data

Improving Molecule Generation and Drug Discovery with a Knowledge-enhanced Generative Model

Diffusing on Two Levels and Optimizing for Multiple Properties: A Novel Approach to Generating Molecules with Desirable Properties

Hybrid Quantum Generative Adversarial Networks for Molecular Simulation and Drug Discovery

Improving Molecular Design by Stochastic Iterative Target Augmentation

Generative AI for Bayesian Computation

Abstract 7373: Generative Bayesian networks for augmentation of molecular data from commercial genetics panels

Learning Neural Generative Dynamics for Molecular Conformation Generation

Gaussian Process Regression-Based Near-Infrared d -Luciferin Analogue Design Using Mutation-Controlled Graph-Based Genetic Algorithm

Graph-Based Molecular Pareto Optimisation

Beam Enumeration: Probabilistic Explainability For Sample Efficient Self-conditioned Molecular Design

Large Language Models as In-context AI Generators for Quality-Diversity

Diversity oriented Deep Reinforcement Learning for targeted molecule generation

Leveraging Active Subspaces to Capture Epistemic Model Uncertainty in Deep Generative Models for Molecular Design

Zero Shot Molecular Generation via Similarity Kernels